Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients.
10.3760/cma.j.issn.1007-3418.2015.09.001
- VernacularTitle:聚乙二醇干扰素在中国丙型肝炎治疗中的地位
- Author:
Xiaoguang DOU
1
;
Lai WEI
;
Hong REN
;
Hongfei ZHANG
;
Wenhong ZHANG
;
Hui ZHUANG
Author Information
1. Deparment of Infectious Disease, Shengjing Hospital of China Medical University, Shengyang 110004, China.
- Publication Type:Journal Article
- MeSH:
Antiviral Agents;
therapeutic use;
Hepacivirus;
Hepatitis C;
drug therapy;
Humans;
Interferons;
therapeutic use
- From:
Chinese Journal of Hepatology
2015;23(9):641-643
- CountryChina
- Language:Chinese
